LQA300 TM FT-IR system for wine and LactoScope 300TM FT-IR system for liquid dairy include cloud based-software and streamlined workflows to deliver results in under 45 seconds – packaging 100% recyclable supporting company’s sustainability commitment WALTHAM, MA – March 9, PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today launched its... Read more
Ability to import 3D molecular models with one click accelerates information sharing, collaboration and decision making WALTHAM, Mass. – March 2, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced V21 of its ChemDraw® software featuring the ability to import, animate and share 3D chemical structures natively in... Read more
Collaboration aims to evolve precision medicine with cell-specific delivery of gene therapy WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its SIRION Biotech business, a world leader in viral vector-based gene delivery technologies for gene and cell therapy and vaccine development, and the Centre for Genomic Regulation (CRG), an international... Read more
End-to-end solutions designed to help scientists streamline and improvedrug discovery R&D productivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity... Read more
EUROIMMUN assay used to detect previous dengue virus infection will help children and adolescents gain access to vaccine WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 3, 2022– EUROIMMUN, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its EUROIMMUN® Anti-Dengue Virus NS1 Type 1-4 ELISA (IgG) (research use only) was cited by the U.S. Centers for Disease Control and Prevention... Read more
Full-year organic growth, adjusted EBITDA margin expansion, adjusted earnings per share in line with November guidance Full-year revenue of $5.2 billion, up 7% on a reported basis, up 4% organically Full-year reported earnings per share of $2.35, up 68%; adjusted earnings per share of $2.49, up 21% Strong demand drives continuing commercial momentum in all... Read more
FRANKLIN LAKES, N.J., Feb. 3, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its first quarter of fiscal year 2022, which ended December 31, 2021. “Our first quarter results reflect continued execution of our BD2025 strategy and strong base business performance from all three segments.... Read more
– Sport and science combine to advance use of these carbon-neutral fuels in racing and wider auto sector – PerkinElmer tests to analyse fuel and chemical compositions and highlight climate-neutral alternatives to petrol and diesel LONDON, UK – February 2, 2022 – PerkinElmer, a global leader in end-to-end solutions for diagnostics, life sciences, food and... Read more
WALTHAM, Mass., Feb. 2, 2022 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2021. Fourth Quarter and Full Year 2021 Highlights Fourth quarter revenue was $10.70 billion. Fourth quarter GAAP diluted earnings per share (EPS)... Read more